• Clinical Evidence

Safety of EndoTool Versus Fixed-Dose Insulin Infusions for DKA or HHS in the Emergency Department

Setting: 433-bed not-for-profit acute care hospital

Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results

  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.

Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.

Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.
Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.

References

Authors

Meghin Moynihan, PharmD; Brandon Powell, PharmD, BCCCP; Ginger Barrick, PharmD, MSCR, BCPS; Kalynn Northam, PharmD, BCCCP.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 50, Issue 1, p605.

Year

2022

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.
Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.

References

Authors

Meghin Moynihan, PharmD; Brandon Powell, PharmD, BCCCP; Ginger Barrick, PharmD, MSCR, BCPS; Kalynn Northam, PharmD, BCCCP.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 50, Issue 1, p605.

Year

2022

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.